KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 46 filers reported holding KRYSTAL BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,983,600 | +789.3% | 17,100 | +800.0% | 0.05% | +840.0% |
| Q2 2023 | $223,060 | -90.9% | 1,900 | -93.9% | 0.01% | -91.2% |
| Q4 2022 | $2,455,820 | +108.5% | 31,000 | +83.4% | 0.06% | +96.6% |
| Q3 2022 | $1,178,000 | -60.4% | 16,900 | -70.3% | 0.03% | -64.6% |
| Q3 2021 | $2,971,000 | +748.9% | 56,900 | +555.2% | 0.08% | +156.2% |
| Q2 2019 | $350,000 | +67.5% | 8,685 | -13.5% | 0.03% | +6.7% |
| Q4 2018 | $209,000 | – | 10,038 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,913,280 | $153,177,197 | 6.65% |
| Frazier Life Sciences Management, L.P. | 945,407 | $75,689,284 | 5.48% |
| S Squared Technology, LLC | 108,215 | $8,663,693 | 5.14% |
| Nicholas Investment Partners, LP | 374,718 | $29,999,923 | 2.28% |
| Avoro Capital Advisors LLC | 1,750,000 | $140,105,000 | 2.08% |
| Artal Group S.A. | 412,082 | $32,991 | 1.96% |
| First Light Asset Management, LLC | 195,980 | $15,690,159 | 1.41% |
| Integral Health Asset Management, LLC | 85,000 | $6,805,100 | 1.37% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $4,883,660 | 1.36% |
| Hood River Capital Management LLC | 447,393 | $35,818,000 | 1.16% |